Treating Parkinson's Disease Through Transplantation of Autologous Stem Cell-Derived Dopaminergic Neurons

NCT06687837 · clinicaltrials.gov ↗

PHASE1

Phase

RECRUITING

Status

8

Enrollment

OTHER

Sponsor class

Conditions

Parkinson Disease

Interventions

BIOLOGICAL: autologous dopaminergic cell implantation

Sponsor

Jeffrey S. Schweitzer, MD, PhD